Prostate cancer (PCa) is one of the most commonly diagnosed malignancies and among the
leading causes of cancer-related death worldwide. It is a highly heterogeneous disease …

Cancer is one of the most common causes of death worldwide, and its development is a
result of the complex interaction of genetic factors, environmental cues, and aging. Hormone …

As important biomarkers for prostate cancer, total prostate specific antigen (tPSA) and free
prostate specific antigen (fPSA) levels in serum play essential roles in early diagnosis. In this …

Bisphenols and phthalates affect androgen receptor-mediated signaling that directly
regulates Kallikrein-Related serine Peptidase 3 (KLK3) secretion, indicating that …

Liquid biopsy has emerged as new tool for detecting clinically relevant genetic alterations in
cancer patients. The term liquid biopsy is comprehensive and commonly used not only to …

Abstract Prostate Cancer Associated 3 (PCA3) as a promising biomarker to replace serum
prostate-specific antigen (PSA) for differential diagnosis of benign and malignant prostate …

Abstract (DE) Das Prostatakarzinom (PCa) ist die häufigste bösartige Tumorerkrankung des
Mannes in Deutschland. Im Jahr 2019 wurden über 68.000 Neuerkrankungen in …

Sažetak Cilj istraživanja: Ciljevi ovog istraživanja su usporediti laboratorijske i
antropometrijske parametre u bolesnika na androgen deprivirajućoj terapiji iu kontrolnoj …

Objective: To determine the diagnostic accuracy of PSA density in Prostate Cancer, Benign
Prostatic Hyperplasia (BPH) and Prostatitis, taking biopsy as the gold standard. Study …